Each retrieved citation was reviewed by two independently working reviewers. Most articles were excluded on the basis of information provided by the title or abstract. Citations that appeared to be appropriate or those that could not be excluded unequivocally from the title and abstract were identified, and the corresponding full text reports were reviewed by the two reviewers. Any disagreement between them was resolved by reviewer consensus. From the included articles, the following data were extracted: patient demographics, preexisting diagnosis, treatment, follow-up, inclusion/ exclusion criteria, measure and definition of fusion, and fusion rate.
• Between L3 and S1
• ! 18 y of age • Autograft • Regime: • Fusion ¼ > 50% assimilated (in two-segment fusion, both levels had be graded as solidly fused)
• Nonunion ¼ NR (assume < 50% assimilated)
Abbreviations: ALIF, anterior lumbar interbody fusion; AP, anteroposterior; CC, capacitive coupling; CT, computed tomography; DC, direct current; DDD, degenerative disc disease; HNP, herniated nucleus pulpous;
LoE, level of evidence; NR, not reported; PEMF, pulsed electromagnetic field; PLIF, posterior lumbar interbody fusion; RCT, randomized controlled trial.
Evidence-Based Spine-Care Journal 4 Each individual study was rated by two different investigators against preset criteria that resulted in an evidence rating (level of evidence I, II, III, or IV). Disagreements were resolved through discussion. 
III
Moderately high risk Study has significant flaws in design and/or execution that increase potential for bias that may invalidate study results
Moderate or poor quality cohort
• Violation of any of the criteria for good quality cohort
Case-control • Any case-control design
IV

High risk
Study has significant potential for bias; lack of comparison group precludes direct assessment of important outcomes
Case series • Any case series design
Abbreviations: F/U, follow-up; RCT, randomized controlled trial. a Outcome assessment is independent of healthcare personnel judgment. Reliable data are data such as mortality or reoperation. b Authors must provide a description of robust baseline characteristics, and control for those that are unequally distributed between treatment groups. 
Jenis (2000) Kane ( II  II  II  II  II  II Abbreviation: RCT, randomized controlled trial. a Applies only to randomized controlled trials. b Groups must be comparable on baseline characteristics or evidence of control for confounding presented.
Note: Blank cells indicate that the criterion was either not met or that it could not be determined.
Evidence-Based Spine-Care Journal
Determination of Overall Strength of Evidence
After individual article evaluation, the overall body of evidence with respect to each outcome is determined based on precepts outlined by the Grades of Recommendation Assessment, Development and Evaluation (GRADE) Working Group 1 and recommendations made by the Agency for Healthcare Research and Quality (AHRQ). 5 Qualitative analysis is performed considering the following AHRQ required and additional domains.
4 Table 7 provides an outline of the method used to determine the final strength of evidence (SoE).
• Risk of bias is evaluated during the individual study evaluation described above. After individual article review, the literature evidence was rated as "High" initially if the majority of the articles are level I or II. It is rated as "low" if the majority were level III or lower. This is the "baseline" SoE (Table 8 ). The consistency, directness, precision, and subgroup effects are considered for potential "downgrading" the strength of the body of evidence (one or two levels depending on the degree and number of domain violations).
Criteria Evaluated for "Downgrading"
• Consistency refers to the degree of similarity in the effect sizes of different studies within an evidence base. If effect sizes indicate the same direction of effect and if the range of effect sizes is narrow, an evidence base was judged to be consistent. If meta-analyses were conducted, we evaluated the consistency with an "eyeball test." This test consists of a visual appraisal of the forest plots by two independent reviewers. Single study evidence bases were judged "consistency unknown (single study)" and downgraded.
• Directness is concerned with whether the evidence being assessed reflected a single, direct link between the interventions of interest and the ultimate health outcome; that is, a determination of whether the most clinically relevant outcome was measured or a surrogate outcome was assessed. Directness also applies to indirect comparisons of treatment when head-to-head comparisons of interest could not be made within individual studies.
• Precision of evidence pertains to the degree of certainty surrounding an estimate of effect for a specific outcome. This is based on whether the estimate of effect reached statistical significance and/or the inspection of confidence intervals around effect estimates. When there are only two subgroups, the overlap of the confidence intervals of the summary estimates of the two groups is considered. No overlap of the confidence intervals indicates statistical significance, but the confidence intervals can overlap to a small degree and the difference still is statistically significant.
• Subgroup effects: For evaluating subgroup effects (i.e., heterogeneity of treatment effects), we downgrade if the authors do not state a priori their plan to perform subgroup analyses and if there was no test for interaction.
Criteria Used for "Upgrading"
• Finally, if the SoE is less than "High," we "upgrade" the evidence if there is a dose-response association or a strong magnitude of effect.
Strength of Evidence for Existing Systematic Reviews
Level of evidence ratings for Cochrane reviews and other systematic reviews are assigned a baseline score of high if RCTs were used, and low if observational studies were used. The rating can be upgraded or downgraded based on adherence to the core criteria for methods, qualitative, and quantitative analyses for systematic reviews (there is a reference/ evaluation table for this). The following four possible levels and their definition are reported:
• High: High confidence that the evidence reflects the true effect. Further research is very unlikely to change our confidence in the estimate of effect.
• Moderate: Moderate confidence that the evidence reflects the true effect. Further research may change our confidence in the estimate of effect and may change the estimate.
• Low: Low confidence that the evidence reflects the true effect. Further research is likely to change the confidence in the estimate of effect and likely to change the estimate.
• Insufficient: Evidence either is unavailable or does not permit a conclusion. 
